2-(丙烷-2-基氨基)苯酚 | 23504-11-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2-(丙烷-2-基氨基)苯酚
• 英文名称: N-isopropyl-o-aminophenol
• 英文别名: 2-(isopropylamino)phenol；o-(isopropylamino)phenol；2-isopropylamino-phenol；2-(propan-2-ylamino)phenol
• CAS: 23504-11-2
• 化学式: C₉H₁₃NO
• 分子量: 151.208
• InChiKey: BLCSQUZTWKPKSR-UHFFFAOYSA-N

物化性质

• 熔点：
  97-98 °C(Solv: hexane (110-54-3))
• 沸点：
  253.5±23.0 °C(Predicted)
• 密度：
  1.074±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(丙烷-2-基氨基)苯酚 在 三氯化铝 、 乙酸酐 、 碳酸氢钠 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 9.5h， 生成
  参考文献：
  名称：

  6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents

  摘要：

  A series of 6-benzoxazinylpyridazin-3-ones was prepared and evaluated for inhibition of cardiac phosphodiesterase (PDE) fraction III in vitro and for positive inotropic activity in vivo. 6-[3,4-Dihydro-3-oxo-1,4(2H)-benzoxazin-7-yl]-2,3,4,5-tetrahydro-5 - methylpyridazin-3-one (bemoradan) was found to be an extremely potent and selective inhibitor of canine PDE fraction III and a long-acting, potent, orally active inotropic vasodilator agent in various canine models. Additional benzoxazin-6-yl and -8-yl compounds were also prepared. Altering the pyridazinone substitution from the 6-position to the 7-position produced a 14-fold increase in the iv cardiotonic potency (ED50) from 77 to 5.4 micrograms/kg while substitution at the 8-position reduced potency. Methyl substitution at various sites in the molecule was also examined. Positive inotropic activity was maintained for between 8 and 24 h after a single oral dose (100 micrograms/kg) of bemoradan in dogs, thus making it one of the most potent and long-acting orally effective inotropes yet described. Bemoradan is currently under development as a cardiotonic agent for use in the management of congestive heart failure.

  DOI：

  10.1021/jm00163a061
• 作为产物：
  描述：

  O-phenylhydroxylamine 在 氢氧化钾 、 三氟乙酸 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 8.0h， 生成 2-(丙烷-2-基氨基)苯酚
  参考文献：
  名称：

  An Acid-Catalyzed Rearrangement ofN-Alkyl-N′-phenoxyureas; Synthesis of 2-Alkylaminophenols from Phenols

  摘要：

  DOI：

  10.1055/s-1983-30386

文献信息

• FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION
  申请人：Kusakabe Ken-ichi

  公开号：US20120059162A1

  公开（公告）日：2012-03-08

  Provided are a compound represented by general formula (1) and having a TTK inhibitory action and a medicine containing the compound. In formula (1), (X, Y, V, W) is (—N═, ═CR 1 —, ═N—, —CR 7 ═), (—CR 2 ═, ═N—, ═N—, —CR 7 ═), etc.; A is an (un)substituted aromatic hydrocarbon ring, etc.; L is a single bond, —C(═O)—NR A —, etc.; Z is a group represented by the formula —NR 3 R 4 or a group represented by the formula —OR 5 ; R 1 to R 3 , R 6 , and R 7 each is a hydrogen atom, etc.; R 4 and R 5 each is an (un)substituted alkyl, etc.; and R 8 is an (un)substituted cycloalkyl, etc.

  提供了一个由一般式（1）表示的化合物，具有TTK抑制作用，以及含有该化合物的药物。在式（1）中，（X，Y，V，W）为（—N═，═CR1—，═N—，—CR7═），（—CR2═，═N—，═N—，—CR7═），等等；A为（非）取代芳香烃环等；L为一个单键，—C(═O)—NRA—等；Z为由式—NR3R4或式—OR5表示的基团；R1至R3，R6和R7分别是氢原子等；R4和R5分别是（非）取代烷基等；R8是（非）取代环烷基等。
• Diethylenetriamine-Mediated Direct Cleavage of Unactivated Carbamates and Ureas
  作者：Megumi Noshita、Yuhei Shimizu、Hiroyuki Morimoto、Takashi Ohshima

  DOI：10.1021/acs.orglett.6b03016

  日期：2016.12.2

  Diethylenetriamine is effective for the direct cleavage of unactivated carbamates and ureas without additional reagents and catalysts. Various carbamates and ureas were cleaved to afford products in good yield, and the reactions were not affected by air or moisture. Unique chemoselective cleavage of carbamate and urea in the presence of amides was also achieved.

  二亚乙基三胺可直接裂解未活化的氨基甲酸酯和脲，而无需其他试剂和催化剂。裂解各种氨基甲酸酯和尿素以提供高收率的产物，并且反应不受空气或湿气的影响。在酰胺存在下，还可实现氨基甲酸酯和尿素的独特化学选择性裂解。
• Aryl piperidine amides
  申请人：Huang Q. Charles

  公开号：US20050049239A1

  公开（公告）日：2005-03-03

  The invention provides novel GlyT2 inhibiting compounds useful in modulating, treating, or preventing: anxiolytic disorders; a condition requiring treatment of injured mammalian nerve tissue; a condition amenable to treatment through administration of a neurotrophic factor; a neurological disorder; or obesity; an obesity-related disorder.

  该发明提供了新颖的GlyT2抑制化合物，可用于调节、治疗或预防：焦虑症；需要治疗受伤哺乳动物神经组织的状况；适合通过神经营养因子管理治疗的状况；神经系统紊乱；或肥胖症；与肥胖相关的疾病。
• IMIDAZAOLONE DERIVATIVES,PREPARATION THEREOF AND BIOLOGICAL USE OF SAME
  申请人：Carreaux Francois

  公开号：US20100216855A1

  公开（公告）日：2010-08-26

  Imidazolone derivatives, as medicaments, of formula wherein: R 1 ═H, C 1 to C 5 alkyl, aryl or a 5- or 6-membered heterocyclic group; Ar 1 =optionally substituted aryl or an aromatic heterocycle; R═R 2 —S—, R 3 —HN—, R 4 COHN or Ar 2 , with R 2 =a C 1 -C 5 alkyl, vinyl or vinyl(C 1 -C 5 )alkyl, nitrile or nitrile(C 1 -C 5 )alkyl, aryl or benzyl radical, which are optionally substituted; R 3 =the meanings given above and H; Ar 2 =substituted or unsubstituted aryl.

  咪唑酮衍生物，作为药物，具有以下结构：R1═H，C1到C5烷基，芳基或5-或6-成员杂环基；Ar1=可选择的取代芳基或芳香杂环；R═R2—S—，R3—HN—，R4COHN或Ar2，其中R2=一个C1-C5烷基，乙烯基或乙烯基(C1-C5)烷基，腈基或腈基(C1-C5)烷基，芳基或苄基基团，可以选择取代；R3=如上所述的含义和H；Ar2=取代或未取代的芳基。
• Chiral Monodentate Phosphines and Bulky Carboxylic Acids: Cooperative Effects in Palladium-Catalyzed Enantioselective C(sp3)-H Functionalization
  作者：Tanguy Saget、Sébastien J. Lemouzy、Nicolai Cramer

  DOI：10.1002/anie.201108511

  日期：2012.2.27

  important indoline scaffold is provided with enantiomeric ratios of up to 98:2 in palladium(0)‐catalyzed C(sp3)–H activations of aryl triflates. The key is the combination of the electron‐rich monodentate Sagephos and the bulky 9H‐xanthene‐9‐carboxylic acid. Both participate in a highly cooperative manner in the enantiodetermining concerted‐deprotonation‐metalation step (see scheme, Tf=triflate).

  联手：重要的二氢吲哚骨架在钯（0）催化的芳基三氟甲磺酸酯的C（sp 3）–H活化中的对映体比率高达98：2 。关键是富电子的单齿鼠尾草和庞大的9 H-蒽并9-9羧酸的组合。两者都以高度合作的方式参与对映确定一致的去质子化金属化步骤（参见方案，Tf = triflate）。